UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Breathborne Biomarkers and the Human Volatilome

2, 2020

Volltextzugriff (PDF)

The Reliability Of The Patient-Reported Scar Evaluation Questionnaire (Pr-Seq) In A Cohort Of Adults With Linear Scars

Value in health, 2014-05, Vol.17 (3), p.A288-A288

2014

Volltextzugriff (PDF)

Is a picture worth a thousand words? the development of a clinician and patient reported photonumeric guide to assess scar severity

Value in health, 2013-05, Vol.16 (3), p.A31-A31

2013

Volltextzugriff (PDF)

PDB55 The Adaptation of the Injection Pen Assessment Questionnaire for Use in Europe – Validation Results From a Large Multicenter Study of Recombinant Human Growth Hormone Treatment NaÏve Children and Adults

Value in health, 2012-11, Vol.15 (7), p.A503-A503

2012

Volltextzugriff (PDF)

Clinical Significance of Change in the Quality of Life-Assessment of Growth Hormone Deficiency in Adults (QoL-AGHDA) Score in Adult Growth Hormone Deficiency (AGHD)

Value in health, 2013-11, Vol.16 (7), p.A449-A449

2013

Volltextzugriff (PDF)

PSS27 Do Scars Impact Beyond Just Appearance? A Report of the Content Elicitation (CE) Phase in the Development of the Patient Reported Scar Evaluation Quesionnaire (PR-SEQ)

Value in health, 2012-11, Vol.15 (7), p.A573-A573

2012

Volltextzugriff (PDF)

Investment in prolonged thromboprophylaxis with dalteparin improves clinical outcomes after hip replacement

Journal of thrombosis and haemostasis, 2003-05, Vol.1 (5), p.896-906

2003

Volltextzugriff (PDF)

Core outcome set for gene therapy in haemophilia: Results of the coreHEM multistakeholder project

Haemophilia : the official journal of the World Federation of Hemophilia, 2018-07, Vol.24 (4), p.e167-e172

2018

Volltextzugriff (PDF)

Factors Driving Patient Preferences for Growth Hormone Deficiency (GHD) Injection Regimen and Injection Device Features: A Discrete Choice Experiment

Patient preference and adherence, 2020-01, Vol.14, p.781-793

2020

Volltextzugriff (PDF)

Strategische Onlinekommunikation: Theoretische Konzepte und empirische Befunde

2015., 2014

Volltextzugriff (PDF)

PSS15 DEVELOPMENT OF A MULTIATTRIBUTE INSTRUMENT FOR ESTIMATING UTILITIES (PREFERENCE WEIGHTS) IN PEOPLE WITH GLAUCOMA FROM THE NATIONAL EYE INSTITUTE VISUAL FUNCTIONING QUESTIONNAIRE (NEI-VFQ)

Value in health, 2011, Vol.14 (3), p.A56-A56

2011

Volltextzugriff (PDF)

Multinational Study of Reliability and Validity of the King's Health Questionnaire in Patients with Overactive Bladder

Quality of life research, 2003-06, Vol.12 (4), p.427-442

2003

Volltextzugriff (PDF)

Comparison of Length of Hospital Stay for Patients with Known or Suspected Methicillin-Resistant Staphylococcus Species Infections Treated with Linezolid or Vancomycin: A Randomized, Multicenter Trial

Pharmacotherapy, 2001-03, Vol.21 (3), p.263-274

2001

Volltextzugriff (PDF)

PDB125 - A DISCRETE CHOICE EXERCISE TO EVALUATE FACTORS DRIVING GROWTH HORMONE DEFICIENT (GHD) PATIENT PREFERENCES FOR INJECTION AND INJECTION DEVICE FEATURES

Value in health, 2018-10, Vol.21, p.S139-S140

2018

Volltextzugriff (PDF)

Experiencing health‐related quality of life in paediatric short stature – a cross‐cultural analysis of statements from patients and parents

Clinical psychology and psychotherapy, 2017-11, Vol.24 (6), p.1370-1376

2017

Volltextzugriff (PDF)

PSY34 - Factor Dispensation and Expenditures in Hemophilia B Patients Switching from Standard Half-Life to Extended Half-Life Recombinant Factor IX Replacement Products: Real-World Analysis in Japan

Value in health, 2018-09, Vol.21, p.S111-S111

2018

Volltextzugriff (PDF)

PSY35 - Real World Factor Dispensation and Expenditures in us Patients with Hemophilia B: Standard Half-Life vs. Extended Half-Life Factor IX Replacement Products

Value in health, 2018-09, Vol.21, p.S111-S111

2018

Volltextzugriff (PDF)

Real World Factor Dispensation and Expenditures in us Patients with Hemophilia B: Standard Half-Life vs. Extended Half-Life Factor IX Replacement Products

Value in health, 2018-09, Vol.21, p.S111

2018

Volltextzugriff (PDF)

Factor Dispensation and Expenditures in Hemophilia B Patients Switching from Standard Half-Life to Extended Half-Life Recombinant Factor IX Replacement Products: Real-World Analysis in Japan

Value in health, 2018-09, Vol.21, p.S111

2018

Volltextzugriff (PDF)

Real World Data Analysis of US Claims Database on Coagulation Factor IX Expenditures in Patients with Hemophilia B: Standard half-Life Vs. Extended Half-Life Products

Value in health, 2018-05, Vol.21, p.S262

2018

Volltextzugriff (PDF)

PSY110 - Real World Data Analysis of US Claims Database on Coagulation Factor IX Expenditures in Patients with Hemophilia B: Standard half-Life Vs. Extended Half-Life Products

Value in health, 2018-05, Vol.21, p.S262-S262

2018

Volltextzugriff (PDF)

False positive results: a challenge for psychiatric screening in primary care

The American journal of psychiatry, 1997-10, Vol.154 (10), p.1462-1464

1997

Volltextzugriff (PDF)

Real-World Health Care Expenditure In Hemophilia A Patients Using Standard and Extended Half-Life Recombinant Factor Viii Products

Value in health, 2017-10, Vol.20 (9), p.A892

2017

Volltextzugriff (PDF)

PSY14 - Real-World Health Care Expenditure In Hemophilia A Patients Using Standard and Extended Half-Life Recombinant Factor Viii Products

Value in health, 2017-10, Vol.20 (9), p.A892-A892

2017

Volltextzugriff (PDF)

Real-World Health Care Expenditure In Hemophilia A Patients Using Standard And Extended Half-Life Recombinant Factor VIII Products

Value in health, 2017-10, Vol.20 (9), p.A567

2017

Volltextzugriff (PDF)

1 – 25 von 389

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(332)
Mit Volltextzugriff
(326)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(219)
Life Sciences & Biomedicine
(198)
Humans
(138)
Biochemistry & Molecular Biology
(60)
Male
(60)
Biochemical Research Methods
(56)
Toxicology
(49)
Respiratory System
(46)
Female
(45)
Environmental Sciences
(44)
Environmental Sciences & Ecology
(44)
Animals
(37)
Physical Sciences
(35)
Biomarkers
(34)
Biological And Medical Sciences
(30)
Breath Tests
(28)
Public, Environmental & Occupational Health
(28)
Medical Sciences
(27)
Volatile Organic Compounds
(26)
Breath Tests - Methods
(25)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Breathborne Biomarkers and the Human Volatilome

The Reliability Of The Patient-Reported Scar Evaluation Questionnaire (Pr-Seq) In A Cohort Of Adults With Linear Scars

Is a picture worth a thousand words? the development of a clinician and patient reported photonumeric guide to assess scar severity

PDB55 The Adaptation of the Injection Pen Assessment Questionnaire for Use in Europe – Validation Results From a Large Multicenter Study of Recombinant Human Growth Hormone Treatment NaÏve Children and Adults

Clinical Significance of Change in the Quality of Life-Assessment of Growth Hormone Deficiency in Adults (QoL-AGHDA) Score in Adult Growth Hormone Deficiency (AGHD)

PSS27 Do Scars Impact Beyond Just Appearance? A Report of the Content Elicitation (CE) Phase in the Development of the Patient Reported Scar Evaluation Quesionnaire (PR-SEQ)

Investment in prolonged thromboprophylaxis with dalteparin improves clinical outcomes after hip replacement

Core outcome set for gene therapy in haemophilia: Results of the coreHEM multistakeholder project

Factors Driving Patient Preferences for Growth Hormone Deficiency (GHD) Injection Regimen and Injection Device Features: A Discrete Choice Experiment

Strategische Onlinekommunikation: Theoretische Konzepte und empirische Befunde

PSS15 DEVELOPMENT OF A MULTIATTRIBUTE INSTRUMENT FOR ESTIMATING UTILITIES (PREFERENCE WEIGHTS) IN PEOPLE WITH GLAUCOMA FROM THE NATIONAL EYE INSTITUTE VISUAL FUNCTIONING QUESTIONNAIRE (NEI-VFQ)

Multinational Study of Reliability and Validity of the King's Health Questionnaire in Patients with Overactive Bladder

Comparison of Length of Hospital Stay for Patients with Known or Suspected Methicillin-Resistant Staphylococcus Species Infections Treated with Linezolid or Vancomycin: A Randomized, Multicenter Trial

PDB125 - A DISCRETE CHOICE EXERCISE TO EVALUATE FACTORS DRIVING GROWTH HORMONE DEFICIENT (GHD) PATIENT PREFERENCES FOR INJECTION AND INJECTION DEVICE FEATURES

Experiencing health‐related quality of life in paediatric short stature – a cross‐cultural analysis of statements from patients and parents

PSY34 - Factor Dispensation and Expenditures in Hemophilia B Patients Switching from Standard Half-Life to Extended Half-Life Recombinant Factor IX Replacement Products: Real-World Analysis in Japan

PSY35 - Real World Factor Dispensation and Expenditures in us Patients with Hemophilia B: Standard Half-Life vs. Extended Half-Life Factor IX Replacement Products

Real World Factor Dispensation and Expenditures in us Patients with Hemophilia B: Standard Half-Life vs. Extended Half-Life Factor IX Replacement Products

Factor Dispensation and Expenditures in Hemophilia B Patients Switching from Standard Half-Life to Extended Half-Life Recombinant Factor IX Replacement Products: Real-World Analysis in Japan

Real World Data Analysis of US Claims Database on Coagulation Factor IX Expenditures in Patients with Hemophilia B: Standard half-Life Vs. Extended Half-Life Products

PSY110 - Real World Data Analysis of US Claims Database on Coagulation Factor IX Expenditures in Patients with Hemophilia B: Standard half-Life Vs. Extended Half-Life Products

False positive results: a challenge for psychiatric screening in primary care

Real-World Health Care Expenditure In Hemophilia A Patients Using Standard and Extended Half-Life Recombinant Factor Viii Products

PSY14 - Real-World Health Care Expenditure In Hemophilia A Patients Using Standard and Extended Half-Life Recombinant Factor Viii Products

Real-World Health Care Expenditure In Hemophilia A Patients Using Standard And Extended Half-Life Recombinant Factor VIII Products

Suchergebnisse filtern